Header cover image

Capital Goods Healthcare Sector

Results

2306

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2306 companies

Nuformix

Market Cap: UK£1.3m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

NFX

UK£0.0008

7D

-36.0%

1Y

-55.6%

Comprehensive Healthcare Systems

Market Cap: CA$2.5m

Provides healthcare administrative software solutions in the United States.

CHS

CA$0.20

7D

2.6%

1Y

100.0%

Blueberries Medical

Market Cap: CA$2.5m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

BBM

CA$0.005

7D

0%

1Y

-75.0%

VGI Health Technology

Market Cap: AU$2.8m

VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies.

VTL

AU$0.02

7D

0%

1Y

n/a

1933 Industries

Market Cap: CA$2.5m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

TGIF

CA$0.005

7D

0%

1Y

-66.7%

Vaccinex

Market Cap: US$1.8m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

VCNX

US$0.68

7D

-34.6%

1Y

-86.8%

ENDRA Life Sciences

Market Cap: US$1.7m

Develops technologies to improve the capabilities of clinical diagnostic ultrasound.

NDRA

US$3.13

7D

-2.5%

1Y

-99.4%

Medicine Man Technologies

Market Cap: US$1.7m

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.

SHWZ

US$0.02

7D

0%

1Y

-96.0%

RespireRx Pharmaceuticals

Market Cap: US$1.7m

Engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

RSPI

US$0.0016

7D

-11.1%

1Y

128.6%

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

PYC

UK£0.0042

7D

-1.2%

1Y

-67.7%

InVitro International

Market Cap: US$1.7m

Develops test kits for non-animal testing applications in the United States and internationally.

IVRO

US$0.075

7D

24.7%

1Y

-0.3%

Imagion Biosystems

Market Cap: AU$2.6m

Provides medical imaging technologies using magnetic resonance.

IBX

AU$0.013

7D

0%

1Y

n/a

Algernon Pharmaceuticals

Market Cap: CA$2.3m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

AGN

CA$0.09

7D

0%

1Y

-43.8%

United American Healthcare

Market Cap: US$1.7m

Through its subsidiaries, provides contract manufacturing services to the medical device industry.

UAHC

US$0.014

7D

1.4%

1Y

-50.4%

Binovi Technologies

Market Cap: CA$2.3m

Engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.

VISN.H

CA$0.085

7D

0%

1Y

n/a

Kaya Holdings

Market Cap: US$1.6m

A vertically integrated legal cannabis enterprise, engages in the operation of psychedelic treatment clinics and medical cannabis dispensaries primarily in the United States.

KAYS

US$0.039

7D

13.2%

1Y

3.2%

Helix BioMedix

Market Cap: US$1.6m

Operates as a specialty dermatology and consumer products skin health company in the United States.

HXBM

US$7.18

7D

0%

1Y

n/a

TNF Pharmaceuticals

Market Cap: US$1.6m

A clinical-stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.

TNFA

US$0.16

7D

-17.4%

1Y

-91.9%

Osteopore

Market Cap: AU$2.4m

A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, the United States, Malaysia, Indonesia, Netherlands, Thailand, Australia, and internationally.

OSX

AU$0.014

7D

-6.7%

1Y

-80.0%

LungLife AI

Market Cap: UK£1.1m

A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.

LLAI

UK£0.037

7D

7.1%

1Y

-79.7%

Hempshire Group

Market Cap: CA$2.1m

Engages in the production and distribution of CBD Hemp smokes.

HMPG

CA$0.015

7D

0%

1Y

-72.7%

American Green

Market Cap: US$1.5m

Operates as a technology company in the medical cannabis industry in the United States.

ERBB

US$0.00035

7D

16.7%

1Y

-41.7%

MyndTec

Market Cap: CA$2.1m

A medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States.

MYTC

CA$0.08

7D

0%

1Y

-20.0%

GelStat

Market Cap: US$1.5m

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

GSAC

US$0.0004

7D

0%

1Y

0%

Know Labs

Market Cap: US$1.5m

Focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States.

KNW

US$0.48

7D

0.3%

1Y

-98.1%

West Island Brands

Market Cap: CA$2.0m

Engages in the medical marijuana business.

WIB

CA$0.13

7D

0%

1Y

4.0%

Procyon

Market Cap: US$1.5m

Manufactures and markets wound and skin care products primarily in the United States.

PCYN

US$0.18

7D

0%

1Y

-17.6%

Alterola Biotech

Market Cap: US$1.5m

A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.

ABTI

US$0.001

7D

0%

1Y

-69.7%

Restart Life Sciences

Market Cap: CA$2.0m

Through its subsidiaries, operates as a biotechnology company worldwide.

HEAL

CA$0.06

7D

0%

1Y

-60.0%

Bio-Path Holdings

Market Cap: US$1.4m

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

BPTH

US$0.18

7D

-2.2%

1Y

-91.2%

SOHM

Market Cap: US$1.4m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

SHMN

US$0.0007

7D

0%

1Y

-36.4%

CardioComm Solutions

Market Cap: CA$1.9m

Develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide.

EKG

CA$0.01

7D

0%

1Y

0%

Filament Health

Market Cap: US$1.4m

Operates as a clinical-stage natural psychedelic drug development company in Canada.

FLHL.F

US$0.014

7D

-16.1%

1Y

-55.8%

Salarius Pharmaceuticals

Market Cap: US$1.4m

Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.

SLRX

US$0.78

7D

-8.5%

1Y

-79.5%

Hexima

Market Cap: AU$2.2m

Does not have significant operations.

HXL

AU$0.013

7D

0%

1Y

-18.8%

Allied

Market Cap: US$1.3m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

ALID

US$0.011

7D

-27.7%

1Y

-92.4%

Page 48 of 65